Inventor · disambiguated record
Larry C. Mattheakis
Also filed as: MATTHEAKIS LARRY · MATTHEAKIS LARRY C
20 granted patents·21 pending applications·1,136 citations·filing 1996–2023
97Inventor score
Files withPROTAGONIST THERAPEUTICS INC20CYTOKINETICS INC3DOWER WILLIAM J3GLAXO WELLCOME INC2LIFE TECHNOLOGIES CORP2
Top patents by PatentIndex Score
41 records- 0198US11111272B2α4α7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·10 cites·14 claims
- 0298US10626146B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·15 cites·22 claims
- 0398US9518091B2A4B7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2016·Granted Dec 13, 2016·34 cites·21 claims
- 0498US5958703AUse of modified tethers in screening compound librariesGLAXO GROUP LTD·Filed 1996·Granted Sep 28, 1999·366 cites·44 claims
- 0598US5922545AIn vitro peptide and antibody display librariesAFFYMAX TECH NV·Filed 1997·Granted Jul 13, 1999·324 cites·4 claims
- 0697US10059744B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·22 cites·31 claims
- 0797US9809623B2α4β7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·26 cites·14 claims
- 0897US9714270B2a4B7 integrin thioether peptide antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·27 cites·22 claims
- 0995US10729676B2Opioid agonist peptides and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2019·Granted Aug 4, 2020·10 cites·18 claims
- 1095US9273093B2α4β7 peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2013·Granted Mar 1, 2016·31 cites·8 claims
- 1194US10278957B2Opioid agonist peptides and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·16 cites·19 claims
- 1292US6465430B1Peptides and compounds that bind to a thrombopoietin receptorSMITHKLINE BEECHAM CORP·Filed 2000·Granted Oct 15, 2002·52 cites·20 claims
- 1389US6083913APeptides and compounds that bind to a thrombopoietin receptorGLAXO WELLCOME INC·Filed 1996·Granted Jul 4, 2000·74 cites·31 claims
- 1488US11840581B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Dec 12, 2023·1 cites·17 claims
- 1588US7091311B2Peptides and compounds that bind to a receptorSMITHKLINE BEECHAM CORP·Filed 2002·Granted Aug 15, 2006·19 cites·9 claims
- 1686US8227422B2Peptides and compounds that bind to a receptorDOWER WILLIAM J·Filed 2006·Granted Jul 24, 2012·8 cites·7 claims
- 1786US2024209026A1A4b7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1884US6309842B1Use of modified tethers in screening compound librariesGLAXO WELLCOME INC·Filed 1997·Granted Oct 30, 2001·62 cites·4 claims
- 1982US7817840B2Predicting hepatotoxicity using cell based assaysCYTOKINETICS INC·Filed 2006·Granted Oct 19, 2010·20 cites·19 claims
- 2081US8993349B2Method for enhancing transport of semiconductor nanocrystals across biological membranesBRUCHEZ MARCEL P·Filed 2010·Granted Mar 31, 2015·6 cites·21 claims
- 2175US2022162261A1NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2273US7235353B2Predicting hepatotoxicity using cell based assaysCYTOKINETICS INC·Filed 2003·Granted Jun 26, 2007·13 cites·19 claims
- 2372US2020239523A1NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2461US2018148477A1NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2559US2009214489A1Peptides and compounds that bind to a receptorDOWER WILLIAM J·Filed 2008·Application pending·0 cites
- 2659US2016161496A1Cells Having A Spectral Signature And Methods Of Preparation And Use ThereofLIFE TECHNOLOGIES CORP·Filed 2015·Application pending·0 cites
- 2758US2019248870A1NOVEL a4ß7 PEPTIDE DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2855US2006058240A1Peptides and compounds that bind to a receptorDOWER WILLIAM J·Filed 2005·Application pending·0 cites
- 2955US2007148634A1Cells having a spectral signature and methods of preparations and use thereofINVITROGEN CORP·Filed 2007·Application pending·0 cites
- 3054US2023063321A1Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 Integrin AntagonistsGUPTA SUNEEL KUMAR·Filed 2021·Application pending·0 cites
- 3153US2014294902A1Novel a4b7 peptide antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3253US2020017549A1NOVEL a4B7 PEPTIDE ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3353US2014294901A1Novel a4b7 peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3450US2016368966A1NOVEL a4B7 PEPTIDE DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3547US2005059031A1Method for enhancing transport of semiconductor nanocrystals across biological membranesQUANTUM DOT CORP·Filed 2003·Application pending·0 cites
- 3647US2015198606A1Method for enhancing transport of semiconductor nanocrystals across biological membranesLIFE TECHNOLOGIES CORP·Filed 2015·Application pending·0 cites
- 3747US2004023261A1Micelles comprising semiconductor nanocrystals and uses thereofFiled 2003·Application pending·0 cites
- 3844US2002155507A1Cells having a spectral signature, and methods of preparation and use thereofFiled 2001·Application pending·0 cites
- 3941US2002164777A1Devices and methods for high throughput patch clamp assaysFiled 2001·Application pending·0 cites
- 4041US2019270786A1Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4138US2005014217A1Predicting hepatotoxicity using cell based assaysCYTOKINETICS INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Larry C. Mattheakis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →